Mesenchymal Stem Cells in the Treatment of Amyotrophic Lateral Sclerosis

被引:21
|
作者
Hajivalili, Mahsa [1 ,2 ]
Pourgholi, Fatemeh [1 ,2 ]
Kafil, Hossein Samadi [3 ]
Jadidi-Niaragh, Farhad [1 ,2 ,4 ]
Yousefi, Mehdi [1 ,2 ,3 ]
机构
[1] Tabriz Univ Med Sci, Immunol Res Ctr, Tabriz, Iran
[2] Tabriz Univ Med Sci, Fac Med, Dept Immunol, Tabriz, Iran
[3] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran
[4] Univ Tehran Med Sci, Sch Publ Hlth, Dept Immunol, Tehran, Iran
关键词
Amyotrophic lateral sclerosis; mesenchymal stem cells; stem cell; treatment; MARROW STROMAL CELLS; HUMAN ADIPOSE-TISSUE; RAT MODEL; DISEASE PROGRESSION; GROWTH-FACTORS; MOUSE MODEL; TRANSPLANTATION; ALS; BRAIN; DELIVERY;
D O I
10.2174/1574888X10666150902095031
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder which is characterized by motor neuron (MN) dysfunction, progressive paralysis, and death. Although several therapeutic approaches have been used for treatment of ALS, little success has been achieved. Natural vectors such as mesenchymal stem cells (MSCs) can be a promising tool for overcoming therapeutic problems. MSCs have multipotential characteristics such as the ability to differentiate into variety of cell types, easy access, immunomodulation, tissue repair, exertion of trophic factors, exosome secretion and efficient homing. In this review, we will discuss the characteristics of MSCs and their possible therapeutic mechanisms in ALS patients.
引用
收藏
页码:41 / 50
页数:10
相关论文
共 50 条
  • [21] Mesenchymal stem cells significantly improve survival in an experimental model of amyotrophic lateral sclerosis
    MariaCristina, Principato
    Sara, Morando
    Simona, Casazza
    Debora, Giunti
    Laura, Vergani
    Adriana, Voci
    Claudia, Caponnetto
    Gianbattista, Bonanno
    Antonio, Uccelli
    Marco, Milanese
    JOURNAL OF NEUROIMMUNOLOGY, 2010, 228 (1-2) : 151 - 151
  • [22] Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis (vol 9, 695900, 2021)
    Sykova, Eva
    Cizkova, Dasa
    Kubinova, Sarka
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [23] Stem cells therapy in amyotrophic lateral sclerosis treatment. A critical view
    Soler, Bernardita
    Fadic, Ricardo
    von Bernhardi, Rommy
    REVISTA DE NEUROLOGIA, 2011, 52 (07) : 426 - 434
  • [24] Intravenous Mesenchymal Stem Cells Improve Survival and Motor Function in Experimental Amyotrophic Lateral Sclerosis
    Uccelli, Antonio
    Milanese, Marco
    Principato, Maria Cristina
    Morando, Sara
    Bonifacino, Tiziana
    Vergani, Laura
    Giunti, Debora
    Voci, Adriana
    Carminati, Enrico
    Giribaldi, Francesco
    Caponnetto, Claudia
    Bonanno, Giambattista
    MOLECULAR MEDICINE, 2012, 18 (05) : 794 - 804
  • [25] Overview of stem cells therapy in amyotrophic lateral sclerosis
    Je, Goun
    Keyhanian, Kiandokht
    Ghasemi, Mehdi
    NEUROLOGICAL RESEARCH, 2021, 43 (08) : 616 - 632
  • [26] Preclinical studies of mesenchymal stem cells transplantation in amyotrophic lateral sclerosis: a systemic review and metaanalysis
    Qi Zhou
    Min Yuan
    Weiwen Qiu
    Wenfeng Cao
    Renshi Xu
    Neurological Sciences, 2021, 42 : 3637 - 3646
  • [27] Stem cells as a novel therapy for amyotrophic lateral sclerosis
    Moore, P. J. A.
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2015, 72 (02) : 74 - 75
  • [28] The Therapeutic Potential of Stem Cells in Amyotrophic Lateral Sclerosis
    Mitrecic, Dinko
    Nicaise, Charles
    Gajovic, Srecko
    Pochet, Roland
    CURRENT SIGNAL TRANSDUCTION THERAPY, 2011, 6 (03) : 341 - 346
  • [29] Amyotrophic lateral sclerosis: applications of stem cells - an update
    Cova, Lidia
    Silani, Vincenzo
    STEM CELLS AND CLONING-ADVANCES AND APPLICATIONS, 2010, 3 : 145 - 156
  • [30] Stem cells in amyotrophic lateral sclerosis: state of the art
    Mazzini, Letizia
    Vercelli, Alessandro
    Ferrero, Ivana
    Mareschi, Katia
    Boido, Marina
    Servo, Serena
    Oggioni, Gaia Donata
    Testa, Lucia
    Monaco, Francesco
    Fagioli, Franca
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2009, 9 (10) : 1245 - 1258